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Transforming growth factor-p (TGF-fl) is a prototype of a family of polypeptides that regulates cellular growth and phe- 
notypic differentiation [(1986) Science 233, 532-534; (1987) Cell 49, 437-438]. TGF-p injection induces angiogenesis and 
fibrosis locally [(1986) Proc. Natl. Acad. Sci. USA 83, 4167-4171; (1987) Science 237, 1333-1336] and stimulates the syn- 
thesis of extraeellular matrix proteins, fibronectin, collagens, and proteogiycans i  vitro in many cell types [(1986) J. Biol. 
Chem. 261, 4337-4345; (1987) Biocbem J. 247, 597-604]. Ascorbate isalso known to induce collagen synthesis and to 
promote wound healing [(1988) J. Invest. Dermatol, 90, 420-424; (1986) Coll. Rel. Res. 6, 455-466]. We report hat in 
cultured human skin fibroblasts, aseorbate and TGF-fl synergistically enhance the biosynthesis of type I and III collagens 
and their steady-state mRNAs. TGF-p alone has no enhancing effect on type III collagen synthesis. The cooperation 
between ascorbate and TGF-~ may be of significance in wound healing and in disorders of fibrosis. 
Transforming growth factor-fl; Ascorbate; Vitamin C; Collagen; (Dermal f broblast) 
1. INTRODUCTION 
Beta type transforming rowth factors (TGF-fl) 
are disulfide-linked homo- and heterodimers of 
two related 12.5 kDa peptide chains, ~1 and if2, 
which bind to cell surface receptors present on 
many ceils [2,9,10]. The~l  andff2 homodimers are 
the most abundant forms [9]. TGF-~ inhibits 
epithelial and endothelial cells, T and B lym- 
phocytes [5,11], while strongly stimulating the ex- 
pression of extracellular matrix components [3,5], 
cell adhesion receptors [12], and protease in- 
hibitors [13]. Clot retraction time is increased in 
vitro [14], while protease synthesis is decreased 
[13]. Although TGF-fl is known to increase type I 
collagen synthesis [3,5], the exact mechanism of 
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action is unknown. Steady-state collagen mRNAs 
are increased, but may result from stabilization 
rather than a change in the rate of transcription 
[6,15]. Recent studies have shown that a nuclear 
factor 1 binding site in the t~2(I) collagen gene 
mediates the transcription of the promoter by 
TGF-• [161. 
The importance of vitamin C (ascorbic acid) in 
the metabolism of the connective tissue was first 
studied in 1747 by the British naval surgeon James 
Lind [17]. Ascorbate is not only a cofactor for the 
hydroxylation of proline and lysine residues im- 
portant for crosslinking, but it also increases 
transcription of type I and I I I  procollagen mRNAs 
[7]. 
Although human skin fibroblasts can synthesize 
both procollagens in vitro [18], adult skin is com- 
posed of 80°70 type I and 15070 type I I I  collagen. 
The latter is more abundant in the fetal stage [19]. 
Type I collagen is a heterodimer of two c~-chains, 
[od(I)]2 ce2(I), products of genes on chromosomes 
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17 [20] and 7 [20]. Type III collagen, [trl(III)]3, is 
produced by a gene on chromosome 2 [21]. The 
tissue-specific regulation of these collagens may 
depend on nuclear-binding proteins, which could 
be induced by growth factors such as TGF-/5' or 
ascorbate [16]. 
We investigated whether some of the enhance- 
ment of collagen production attributed to TGF-/3 
alone in reported studies [3,6,15] could be partially 
attributed to the presence of ascorbate in the 
culture media. We labeled explanted skin 
fibroblasts from seven donors (ages 11 months to 
79 years, p < 6) with [3H]proline in the presence of 
ascorbate, TGF-/3, both or media alone at 24 and 
72 h. [3H]Proline incorporation into pepsin resis- 
tant proteins (collagens) was analyzed following 
SDS-polyacrylamide gel electrophoresis (SDS- 
PAGE) and fluorography, using laser den- 
sitometry and by trichloroacetic acid (TCA)- 
precipitable counts. 
2. MATERIALS AND METHODS 
2.1. Experimental conditions 
Triplicate cultures (5 x 105 cells, p < 6) were plated and swit- 
ched to media alone (DMEM plus 0.5070 calf serum) or ascor- 
bate (50/zg/ml, Sigma Chemical Company, St. Louis, MO, 
USA), TGF-~ (200 pM, Collaborative Research Incorporated, 
Bedford, MA, USA) or both and cultured for 72 h with fresh 
media daily and then 2,3,4-[3H]proline (1 mCi/ml, Amersham, 
Arlington Heights, IL, USA) was added for a 24 h labeling 
period. Cell numbers did not vary significantly. 
2.2. Assays for pepsin-resistant proteins (collagens) 
Procollagens from media and cell pellets were extracted and 
digested with pepsin as previously described [22]. The samples 
were divided for analysis by 10% TCA precipitation and scin- 
tillagraphy (LKB 1211 Rackbeta liquid scintillation counter) 
and by 5.0°70 SDS-polyacrylamide g l electrophoresis followed 
by fluorography and scanning densitometry (LKB 2202 
Ultroscan Laser Densitometer and LKB 2190 GelScan 
software). 
2.3. Northern blot analysis 
Confluent human skin fibroblast cultures from each of 4 cell 
lines were stimulated for 24 h as described in fig. 1. Total RNAs 
were extracted using guanidine isothiocyanate as described [23] 
and 15/~g of total RNA was loaded per lane on a 1.0% agarose 
formaldehyde gel. The RNA was transferred to nitrocellulose 
paper [24] and hybridized to [32p]dCTP (3000 mCi, Amer- 
sham, Arlington Heights, IL, USA) oligo-labeled eDNA probes 
[25]. The eDNA probe for oel(I), Hf-404, was kindly provided 
by F. Ramirez, the cDNA probe for al(III), PDT 1010, by B. 
de Crombrugghe, and the eDNA probe for B-tubulin (control) 
by F. Cabral. 
3. RESULTS 
3.1. Effect of TGF-/3 and ascorbate on type I and 
Il l  collagen production 
As shown in fig.l, pepsin-resistant proteins 
labeled with [3H]proline are increased by ascor- 
bate, TGF-/3, and both over control media in two 
representative c ll lines. There was no increase in 
the cell numbers in triplicate cultures. Both the tr 1 
and ce2 chains of type I collagen were increased by 
TGF-fl and ascorbate. The trl chain of type III 
Col ]]] A1 
CoIIA1 
Col [A2 
Negative 
Control 
Ascorbate TGF-p Ascorbate 
+ 
TGF-[3 
A 11 MONTH OLD DONOR 
Control 
Col ]]] A1 
Col IA1 
Col I A2 
+ 
TGF-~ 
E5 40 YEAR OLD DONOR 
Fig.1. Effects of ascorbate and TOF-b' on types 1 and II1 
collagen synthesis by cultured human dermal fibroblasts. 
Compared with the negative controls, both ascorbate alone and 
TGF-~ alone resulted in enhanced production (4- to 8-fold) of 
tr l0) and 0e2(I) collagen chains, versus a 22-fold increase with 
both together. No od(III) was seen with TGF-~3 alone compared 
to a faint amount (negative control) and a prominent band with 
ascorbate alone. Other non-collagen proteins were not seen 
following pepsin treatment although faint, incompletely 
processed procollagen chains are present in some lanes. There 
was synergism with both ascorbate plus TGF-B. The 
autoradiographs (11 m o and 40 y o) are representative of the 
seven cell lines studied. 
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showed enhanced synthesis with both TGF-/3 and 
ascorbate but was significantly induced by ascor- 
bate alone over controls. Both laser densitometry 
and scintillation counts of pepsin-resistant, TCA- 
precipitable proteins (table 1 and fig.2), showed 
synergism of collagen production with TGF-/3 and 
ascorbate combined. Using the three way analysis 
of variance, ANOVA, the synergism was signifi- 
cant within the triplicate samples of each of the 
seven different cell lines and additionally, using the 
mean values for the lines collectively (p < 0.05). 
There was an age-related decrease in response to 
TGF-/3 and ascorbate, but this was not statistically 
significant (p = 0.08). 
3.2. Effect of TGF-/~ and ascorbate on steady- 
state mRNAs for type I and III collagens 
To determine whether there was synergistic 
enhancement of the steady-state mRNAs for tr I (I), 
Table 1 
[3H]Proline incorporation into pepsin resistant proteins 
(collagens) 
Control Ascorbate TGF-/3 TGF-b'and 
ascorbate 
combined 
Scintillation counts - total collagen in media samples 
radioactivity in cpm 
11 m o 11320 18268 29962 67223 
1 y o 18246 54919 42400 191549 
40 y o 27474 48355 47827 69265 
45 y o 5198 10321 4072 12657 
64 y o 13563 20072 49380 90447 
74 y o 16218 18772 19902 86980 
79 y o 12546 21434 28779 31239 
Densitometer measurements - type I and type III combined 
11 m o 67 697 175 2654 
1 y o 11 2115 95 4846 
40 y o 470 2628 781 3759 
45 y o 0 131 43 504 
64y o 226 1017 942 5088 
74 y o 24 18 22 3236 
79 y o 183 844 1491 2307 
Human skin fibroblasts explanted from seven donors were 
plated, stimulated and the [3H]proline-labeled pepsin-resistant 
proteins were extracted as described in riga [22]. The cpm 
represent the mean of triplicate samples for each condition. The 
synergistic effects of TGF-~' and ascorbate on pepsin resistant, 
TCA precipitable proteins were confirmed by laser 
densitometry measurements of fluorographs of SDS- 
polyacrylamide g ls. Two cell lines (11 m o and 40 y o) were 
repeated with similar results (not shown) 
80,000 
60,000 
E 40,000 
o .  
I~ 20,000 
0 ~ Control Vl! C TGF-I~ Both 
Fig.2. Synergistic effect of ascorbate and TGF-~ on total 
collagen production in cultured human skin fibroblasts. The 
data was analyzed using 3-factor analysis of variance [Vitamin 
C, TGF-~', and age group (< 10 years, 10-50 years, and >50 
years)]. Vitamin C and TGF-~ showed significant increases in 
counts (p < 0.001), while age group showed a nonsignificant 
decrease in counts (p = 0.08). The only significant interaction 
was vitamin C by TGF-~ (p = 0.006). Upon rerun using lOgl0 
(counts) instead of counts, vitamin C and TGF-~ continued 
significant (p < 0.001) while the interaction of vitamin C and 
TGF-/3 became not significant (p = 0.392) indicating a 
'multiplicative effect' and thus synergism [28]. 
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Fig.3. Northern blot analysis of the effect of ascorbate and 
TGF-~ on type I (al) and type III collagen mRNA in cultured 
human skin fibroblasts. (A) Hybridization with a Col 1 A1 
cDNA probe; (B) hybridization with a Col 3 AI cDNA probe; 
(C) equal hybridization to/~-tubulin cDNA control probe; (D) 
total RNA. Laser densitometry showed a 1.5-fold increase in 
Col 1 A1 (5.8 plus 4.8 kb) with ascorbate and 3.5-fold increase 
with ascorbate and TGF-~', while Col 3 A1 (5.4 plus 4.8 kb) was 
increased 1.5-fold by TGF-/5' and 2.5-fold by ascorhate and 
TGF-B. That the increase in collagen production was greater 
than the rise in mRNA levels suggests an effect of ascorbate and 
TGF-~' on mRNA stabilization and/or on a post-translational 
event. 
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ce2(I), and a~l(III), confluent skin fibroblasts were 
cultured as above, and the mRNAs were extracted 
with guanidine isothiocyanate as described [23]. 
Fig.3 shows the steady-state mRNAs,  analyzed by 
Northern blotting. Steady-state type I and I I I  col- 
lagen mRNAs  were increased 3.5-fold and 
2.5-fold, respectively, with TGF-~ and ascorbic 
acid combined. Unexpectedly, type I I I  mRNA was 
also increased with TGF-~ alone although there 
was no apparent enhancement of the biosynthesis. 
4. D ISCUSSION 
In a study examining the effects of  
1,25-dihydroxyvitamin D3 on types I and I I I  col- 
lagen synthesis, a similar pattern of  collagen 
regulation was found [26]. Type I but not type I I I  
collagen synthesis was stimulated by 1,25-dihy- 
droxyvitamin D3; however, analysis by Northern 
blot hybridization indicated that both type I and 
I I I  procollagen mRNAs were increased 4-fold after 
a 24 h exposure. Of  note, agents that stimulate 
bone resorption, such as 1,25-dihydroxyvitamin 
D3, parathyroid hormone,  and interleukin-1, in- 
crease TGF-~ activity in organ cultures of  fetal rat 
or neonatal mouse calvaria [27]. Whether TGF-~' is 
a direct mediator of  action of  these agents is 
unknown. 
The regulation of  collagen synthesis by TGF-fl is 
complex, and probably involves changes in transla- 
tional efficiency as well as enhanced transcription. 
Previous studies have shown that type I collagen 
and fibronectin steady-state mRNAs  are increased 
in the presence of  TGF-~. The mechanism ay not 
involve increased translation but rather stabiliza- 
t ion of  mRNAs  [6]. Vitamin C increases both types 
I and I I I  collagen mRNA translation by 2- to 
3-fold, and may also decrease its degradation [7]. 
The synergistic enhancement o f types I and I I I  col- 
lagen biosynthesis by ascorbate and TGF-~' may 
result f rom an increase in translation and/or  a 
decrease in mRNA degradation. Finally, vitamin C 
could hypothetically interact with TGF-fl induced 
nuclear binding proteins at the level o f  the collagen 
gene enhancer. 
Our results suggest hat attention to the presence 
of  ascorbate in experimental systems used to test 
the effects of  TGF-d  would be critical, and may 
contribute to the development of  clinical protocols 
for improved wound healing. 
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